Trevor A Mori Selected Research

Omega-3 Fatty Acids (Omega 3 Fatty Acids)

12/2022	Prospective dietary polyunsaturated fatty acid intake is associated with trajectories of fatty liver disease: an 8 year follow-up study from adolescence to young adulthood.
1/2019	Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
4/2018	Reprint of: Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease.
1/2018	The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
12/2017	Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
11/2017	Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease.
1/2017	Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.
4/2016	A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.
3/2016	n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease.
2/2016	n-3 Fatty acid supplementation and proresolving mediators of inflammation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Trevor A Mori Research Topics

Disease

30	Inflammation (Inflammations) 10/2021 - 07/2002
22	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
17	Insulin Resistance 01/2022 - 06/2002
16	Hypertension (High Blood Pressure) 01/2019 - 11/2002
13	Non-alcoholic Fatty Liver Disease 01/2022 - 10/2009
13	Obesity 01/2020 - 05/2002
10	Atherosclerosis 10/2021 - 05/2002
9	Overweight 01/2019 - 10/2004
8	Coronary Disease (Coronary Heart Disease) 04/2018 - 02/2003
7	Chronic Renal Insufficiency 01/2018 - 09/2009
6	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2006
6	Body Weight (Weight, Body) 05/2015 - 10/2004
6	Abdominal Obesity 02/2003 - 05/2002
5	Arteriovenous Fistula 11/2020 - 01/2017
5	Thrombosis (Thrombus) 01/2019 - 01/2004
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2009
4	Heart Diseases (Heart Disease) 12/2021 - 08/2008
4	Weight Loss (Weight Reduction) 01/2009 - 10/2004
3	Chronic Disease (Chronic Diseases) 07/2020 - 02/2011
3	Dyslipidemias (Dyslipidemia) 01/2020 - 08/2002
3	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 10/2016
3	Hypoxia (Hypoxemia) 01/2019 - 01/2012
3	Critical Illness (Critically Ill) 10/2017 - 11/2008
3	Stroke (Strokes) 12/2011 - 11/2004
3	Ischemic Stroke 12/2011 - 11/2004
3	Myocardial Infarction 09/2006 - 11/2004
2	Fatty Liver 12/2022 - 10/2021
2	Reperfusion Injury 02/2021 - 05/2011
2	AIDS-Related Complex (ARC) 01/2021 - 06/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2020 - 11/2010
2	Pain (Aches) 01/2020 - 11/2013
2	Sepsis (Septicemia) 01/2019 - 10/2017
2	Neoplasms (Cancer) 01/2019 - 01/2012

Drug/Important Bio-Agent (IBA)

29	LipidsIBA 12/2021 - 06/2002
27	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2022 - 11/2002
13	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2004
10	C-Reactive ProteinIBA 12/2020 - 06/2002
10	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2019 - 10/2003
10	AntioxidantsIBA 01/2015 - 08/2003
9	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 03/2004
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 12/2005
8	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 10/2021 - 05/2008
8	Fish OilsIBA 10/2021 - 06/2002
8	Insulin (Novolin)FDA Link 01/2021 - 08/2002
8	HDL CholesterolIBA 12/2020 - 03/2011
8	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2016 - 08/2003
7	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2022 - 08/2013
7	Docosahexaenoic AcidsIBA 01/2018 - 11/2002
7	Eicosapentaenoic AcidIBA 01/2018 - 11/2002
7	GlucocorticoidsIBA 05/2014 - 03/2004
6	LeptinIBA 12/2020 - 10/2004
6	Inflammation MediatorsIBA 01/2020 - 04/2016
5	dimemorfan (AT 17)IBA 01/2022 - 05/2013
5	Biological ProductsIBA 12/2021 - 03/2006
5	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 03/2011
5	Free RadicalsIBA 02/2021 - 04/2006
5	CholesterolIBA 12/2020 - 01/2002
5	EnzymesIBA 01/2020 - 09/2005
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2013
4	ApolipoproteinsIBA 08/2020 - 08/2005
4	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020 - 07/2005
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 06/2015
4	SodiumIBA 01/2019 - 05/2008
4	Apolipoprotein B-100 (Apo B 100)IBA 02/2003 - 05/2002
3	LDL CholesterolIBA 12/2021 - 03/2016
3	Pharmaceutical PreparationsIBA 12/2021 - 02/2007
3	Apolipoproteins E (ApoE)IBA 10/2021 - 08/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021 - 08/2003
3	AdiponectinIBA 12/2020 - 03/2011
3	AdipokinesIBA 12/2020 - 03/2011
3	Apolipoproteins B (ApoB)IBA 08/2020 - 08/2002
3	Lipoproteins (Lipoprotein)IBA 08/2020 - 08/2002
3	Furosemide (Lasix)FDA LinkGeneric 01/2019 - 10/2016
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 08/2002
3	coenzyme Q10 (CoQ10)IBA 01/2018 - 09/2009
3	AcidsIBA 10/2017 - 12/2011
3	hydroxide ionIBA 01/2016 - 06/2014
3	NAD (NADH)IBA 01/2015 - 01/2014
3	IsoprostanesIBA 06/2014 - 09/2005
3	NeuroprostanesIBA 06/2014 - 11/2011
3	Messenger RNA (mRNA)IBA 02/2013 - 01/2006
3	Arachidonic Acid (Vitamin F)IBA 01/2012 - 05/2008
3	Superoxides (Superoxide)IBA 05/2010 - 03/2004
3	Atorvastatin (Lipitor)FDA Link 08/2002 - 05/2002
2	Dietary Fats (Dietary Fat)IBA 12/2022 - 02/2011
2	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 12/2022 - 11/2013
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 05/2002
2	Leukotriene B4IBA 10/2021 - 01/2018
2	AntiemeticsIBA 10/2021 - 01/2020
2	EicosanoidsIBA 10/2021 - 11/2013
2	Oxygen (Dioxygen)IBA 02/2021 - 12/2017
2	Alanine Transaminase (SGPT)IBA 01/2021 - 03/2011
2	CalciumIBA 06/2020 - 06/2012
2	Vasoconstrictor AgentsIBA 01/2019 - 05/2008

Therapy/Procedure

5	Secondary Prevention 02/2021 - 03/2006
4	Renal Dialysis (Hemodialysis) 11/2020 - 01/2017
2	Tourniquets 02/2021 - 05/2011
2	Central Venous Catheters 01/2019 - 01/2017
2	Therapeutics 01/2018 - 12/2017